Key statistics
On Monday, AnaptysBio Inc (AN6:FRA) closed at 22.80, 85.37% above the 52 week low of 12.30 set on Nov 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.20 |
---|---|
High | 22.80 |
Low | 21.00 |
Bid | -- |
Offer | -- |
Previous close | 22.80 |
Average volume | 285.00 |
---|---|
Shares outstanding | 30.43m |
Free float | 29.90m |
P/E (TTM) | -- |
Market cap | 677.65m USD |
EPS (TTM) | -6.07 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 20:55 GMT.
More ▼
Announcements
- Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
- Anaptys Announces Participation in November and December Investor Conferences
- Anaptys Announces Participation in September Investor Conferences
- Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
- Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
- Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
- Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
- Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties
- Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
More ▼